Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLH | Q9Y253 | 4/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | APEX1 | P27695 | 2/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | MCL1 | Q07820 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.83 |
| ▸ | MAPT | P10636 | 3/20 | 0.81 |
| ▸ | MEN1 | O00255 | 2/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.81 |
| ▸ | MMP1 | P03956 | 1/20 | 0.81 |
| ▸ | GAA | P10253 | 1/20 | 0.81 |
| ▸ | HTT | P42858 | 1/20 | 0.81 |
| ▸ | BLM | P54132 | 1/20 | 0.81 |
| ▸ | TUBB4A | P04350 | 2/20 | 0.77 |
| ▸ | TUBB | P07437 | 2/20 | 0.77 |
| ▸ | TUBA3C | P0DPH7 | 2/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isokaempferide SCHEMBL29721227 | 1.00 | POLH (1.00) | POLHCYP3A4CYP2D6KDM4EPOLB | |
| Ermanin SCHEMBL2875089 | 0.92 | CYP3A4 (1.00) | POLHCYP3A4CYP2D6KDM4EPOLB | |
| SCHEMBL3188065 | 0.91 | POLH (0.83) | POLHCYP3A4CYP2D6KDM4EPOLB | |
| SCHEMBL15361036 | 0.91 | POLH (0.83) | POLHCYP3A4CYP2D6KDM4EPOLB | |
| SCHEMBL11096105 | 0.91 | POLH (0.83) | POLHCYP3A4CYP2D6KDM4EPOLB | |
| SCHEMBL4631662 | 0.91 | ABCB1 (1.00) | POLHCYP3A4CYP2D6KDM4EPOLB | |
| Kumatakenin SCHEMBL3351483 | 0.91 | KDM4E (0.83) | POLHCYP3A4CYP2D6KDM4EPOLB | |
| Kumatakenin SCHEMBL29681818 | 0.91 | KDM4E (0.83) | POLHCYP3A4CYP2D6KDM4EPOLB | |
| SCHEMBL2284176 | 0.90 | CYP3A4 (0.81) | POLHCYP3A4CYP2D6KDM4EPOLB | |
| 3-O-Methylquercetin SCHEMBL380558 | 0.90 | POLH (1.00) | POLHCYP3A4CYP2D6KDM4EPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12514278-B2 | Tobacco-derived composition | R.J. REYNOLDS TOBACCO COMPANY (US) | 2026-01-06 | — | — | US | claimed |
| US-20220346435-A1 | TOBACCO-DERIVED COMPOSITION | REYNOLDS TOBACCO CO R (US) | 2022-11-03 | — | — | US | claimed |
| CN-110432537-B | Tobacco-derived O-methylated flavonoid compositions | R.J.雷诺兹烟草公司 | 2022-08-19 | — | — | CN | claimed |
| US-11412775-B2 | Tobacco-derived composition | R.J. REYNOLDS TOBACCO COMPANY (US) | 2022-08-16 | — | — | US | claimed |
| EP-2906055-B1 | METHOD OF EXTRACTING TOBACCO-DERIVED O-METHYLATED FLAVONOID AND USE THEREOF | REYNOLDS TOBACCO CO R (US) | 2020-12-16 | — | — | EP | claimed |
| CN-110432537-A | The flavonoid composition of the methylation of O- derived from tobacco | REYNOLDS TOBACCO CO R | 2019-11-12 | — | — | CN | claimed |
| EP-2906055-A1 | TOBACCO-DERIVED O-METHYLATED FLAVONOID COMPOSITION | R. J. Reynolds Tobacco Company (US) | 2015-08-19 | — | — | EP | claimed |
| CN-104780791-A | Tobacco-derived O-methylated flavonoid compositions | REYNOLDS TOBACCO CO R | 2015-07-15 | — | — | CN | claimed |
| US-20140096780-A1 | TOBACCO-DERIVED COMPOSITION | R.J. REYNOLDS TOBACCO COMPANY (US) | 2014-04-10 | — | — | US | claimed |
| EP-1781235-B1 | ANTI-ALLERGY ACTIVITIES OF ZINGIBER ZERUMBET (L.) SMITH | WHOLESOME LIFE SCIENCE CO LTD (TW) | 2013-12-25 | — | — | EP | claimed |
| US-7588788-B2 | administering a ginger extracts from the root of Zingiber zerumbet Sm to treat an allergic rhinitis, asthma and eczema; nutraceuticals as antiinflammatory agents | WHOLESOME LIFE SCIENCE CO., LTD. (TW) | 2009-09-15 | — | — | US | claimed |
| EP-1781235-A4 | ANTI-HYPERSENSITIVE INFLAMMATION AND ANTI-ALLERGY ACTIVITIES OF ZINGIBER ZERUMBET (L.) SMITH | WHOLESOME LIFE SCIENCE CO LTD (TW) | 2008-07-02 | — | — | EP | claimed |
| EP-1781235-A1 | ANTI-HYPERSENSITIVE INFLAMMATION AND ANTI-ALLERGY ACTIVITIES OF ZINGIBER ZERUMBET (L.) SMITH | Wholesome Life Science Co., Ltd. (TW) | 2007-05-09 | — | — | EP | claimed |
| US-20060083799-A1 | Anti-hypersensitive inflammation and anti-allergy activities of Zingiber zerumbet (L.) Smith | WHOLESOME LIFE SCIENCE CO., LTD. | 2006-04-20 | — | — | US | claimed |
| WO-2006020246-A1 | ANTI-HYPERSENSITIVE INFLAMMATION AND ANTI-ALLERGY ACTIVITIES OF ZINGIBER ZERUMBET (L.) SMITH | LIN TSUNG-CHUNG (US) | 2006-02-23 | — | — | WO | claimed |
| WO-2003026705-A1 | METHODS FOR STERILIZING BIOLOGICAL MATERIALS USING FLAVONOID/FLAVONOL STABILIZERS | CLEARANT, INC. (US) | 2003-04-03 | — | — | WO | claimed |
| US-20030059338-A1 | Methods for sterilizing biological materials using flavonoid/flavonol stabilizers | CLEARANT, INC. | 2003-03-27 | — | — | US | claimed |
| US-4774229-A | ANTITUMOR AGENTS, SKIN DISORDERS, CANCER TREATMENT | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-09-27 | — | — | US | claimed |
| WO-1987006833-A1 | MODIFICATION OF PLANT EXTRACTS FROM ZYGOPHYLLACEAE | CHEMEX PHARMACEUTICALS, INC. (US) | 1987-11-19 | — | — | WO | claimed |
| US-20260117236-A1 | METHODS AND COMPOSITIONS FOR MODULATING TRICHOME DENSITY AND FLAVOR MOLECULE SECRETION | ALTRIA CLIENT SERVICES LLC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | THE BROAD INSTITUTE, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-12514278-B2 | Tobacco-derived composition | R.J. REYNOLDS TOBACCO COMPANY (US) | 2026-01-06 | — | — | US | disclosed |
| US-20250376656-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-12-11 | — | — | US | disclosed |
| EP-4580594-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) | 2025-07-09 | — | — | EP | disclosed |
| CN-120078850-A | Sargentodoxa cuneata-herba patriniae extract, and pharmaceutical composition and application thereof | 扬州大学 | 2025-06-03 | — | — | CN | disclosed |
| US-20240368614-A1 | Composition and Methods for Producing Tobacco Plants and Products Having Increased Phenylalanine and Reduced Tobacco-Specific Nitrosamines (TSNAs) | ALTRIA CLIENT SERVICES LLC (US) | 2024-11-07 | — | — | US | disclosed |
| US-11999961-B2 | Composition and methods for producing tobacco plants and products having increased phenylalanine and reduced tobacco-specific nitrosamines (TSNAs) | ALTRIA CLIENT SERVICES LLC (US) | 2024-06-04 | — | — | US | disclosed |
| EP-4062774-B1 | COMPOSITION AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING INCREASED PHENYLALANINE AND REDUCED TOBACCO-SPECIFIC NITROSAMINES (TSNAS) | ALTRIA CLIENT SERVICES LLC (US) | 2024-03-20 | — | — | EP | disclosed |
| WO-2024046834-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | ANALYTICON DISCOVERY GMBH (DE) | 2024-03-07 | — | — | WO | disclosed |
| EP-4331564-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | Analyticon Discovery GmbH (DE) | 2024-03-06 | — | — | EP | disclosed |
| CN-115554347-B | Virus inhibitor and preparation method and application thereof | 河南农业大学 | 2023-09-19 | — | — | CN | disclosed |
| CN-111511406-B | Challenge test for diagnosing autism spectrum disease subtypes | 斯大利卡拉公司 | 2023-04-28 | — | — | CN | disclosed |
| CN-115896007-A | Application of chrysoeriol in preparation of products for promoting embryonic development | 五邑大学 | 2023-04-04 | — | — | CN | disclosed |
| CN-115554347-A | Virus inhibitor and preparation method and application thereof | 河南农业大学 | 2023-01-03 | — | — | CN | disclosed |
| US-20220403402-A1 | Composition and Methods for Producing Tobacco Plants and Products Having Increased Phenylalanine and Reduced Tobacco-Specific Nitrosamines (TSNAs) | ALTRIA CLIENT SERVICES LLC (US) | 2022-12-22 | — | — | US | disclosed |
| US-20220346435-A1 | TOBACCO-DERIVED COMPOSITION | REYNOLDS TOBACCO CO R (US) | 2022-11-03 | — | — | US | disclosed |
| EP-4062774-A1 | COMPOSITION AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING INCREASED PHENYLALANINE AND REDUCED TOBACCO-SPECIFIC NITROSAMINES (TSNAS) | Altria Client Services LLC (US) | 2022-09-28 | — | — | EP | disclosed |
| CN-110432537-B | Tobacco-derived O-methylated flavonoid compositions | R.J.雷诺兹烟草公司 | 2022-08-19 | — | — | CN | disclosed |
| US-11412775-B2 | Tobacco-derived composition | R.J. REYNOLDS TOBACCO COMPANY (US) | 2022-08-16 | — | — | US | disclosed |
| US-20220228190-A1 | MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-07-21 | — | — | US | disclosed |
| US-11377665-B2 | Composition and methods for producing tobacco plants and products having increased phenylalanine and reduced tobacco-specific nitrosamines (TSNAs) | ALTRIA CLIENT SERVICES LLC (US) | 2022-07-05 | — | — | US | disclosed |
| EP-3773017-B1 | COMPOSITION AND METHODS FOR PRODUCING TOBACCO PLANTS AND PRODUCTS HAVING INCREASED PHENYLALANINE AND REDUCED TOBACCO-SPECIFIC NITROSAMINES (TSNAS) | ALTRIA CLIENT SERVICES LLC (US) | 2022-06-08 | — | — | EP | disclosed |
| CN-111603496-B | Suspension artemisia rupestris total flavone nano inclusion preparation and preparation method and application thereof | 新疆维吾尔自治区药物研究所 | 2022-04-22 | — | — | CN | disclosed |
| WO-2022021780-A1 | MEDICATED DIET AND DIETARY THERAPY COMPOSITION FOR TYPE 2 DIABETES AND PREPARATION METHOD THEREFOR | 深圳市老年医学研究所 | 2022-02-03 | — | — | WO | disclosed |
| US-20210228540-A1 | KAEMPFEROL ANALOG-CONTAINING COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2021-07-29 | — | — | US | disclosed |
| WO-2021024041-A1 | CONTROLLED RELEASE DRUG DIMERS | RIPPLE THERAPEUTICS CORPORATION (CA) | 2021-02-11 | — | — | WO | disclosed |
| EP-2906055-B1 | METHOD OF EXTRACTING TOBACCO-DERIVED O-METHYLATED FLAVONOID AND USE THEREOF | REYNOLDS TOBACCO CO R (US) | 2020-12-16 | — | — | EP | disclosed |
| US-20200323816-A1 | KAEMPFEROL ANALOG-CONTAINING COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2020-10-15 | — | — | US | disclosed |
| US-10744114-B2 | Use of eupatilin as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity | OSTEONEUROGEN INC. (KR) | 2020-08-18 | — | — | US | disclosed |
| US-10744113-B2 | Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity | OSTEONEUROGEN INC. (KR) | 2020-08-18 | — | — | US | disclosed |
| WO-2020127888-A2 | URBAN DARKENING SKIN COMPOSITION AND FORMULATION | ORIFLAME COSMETICS AG (CH) | 2020-06-25 | — | — | WO | disclosed |
| CN-107412109-B | Allergy-relieving scalp care solution | 拉芳家化股份有限公司 | 2020-01-17 | — | — | CN | disclosed |
| CN-110432537-A | The flavonoid composition of the methylation of O- derived from tobacco | REYNOLDS TOBACCO CO R | 2019-11-12 | — | — | CN | disclosed |
| US-20190300893-A1 | Composition and Methods for Producing Tobacco Plants and Products Having Increased Phenylalanine and Reduced Tobacco-Specific Nitrosamines (TSNAs) | ALTRIA CLIENT SERVICES LLC (US) | 2019-10-03 | — | — | US | disclosed |
| US-20190231739-A1 | NEW USE OF CHROMONE DERIVATIVE AS PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF FIBROSIS USING EMT INHIBITORY ACTIVITY | OSTEONEUROGEN INC. (KR) | 2019-08-01 | — | — | US | disclosed |
| US-20170239211-A1 | USE OF CHROMONE DERIVATIVE AS PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF FIBROSIS USING EMT INHIBITORY ACTIVITY | OSTEONEUROGEN INC. (KR) | 2017-08-24 | — | — | US | disclosed |
| US-20170239211-A1 | USE OF CHROMONE DERIVATIVE AS PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF FIBROSIS USING EMT INHIBITORY ACTIVITY | OSTEONEUROGEN INC. (KR) | 2017-08-24 | — | — | US | disclosed |
| EP-2906055-A1 | TOBACCO-DERIVED O-METHYLATED FLAVONOID COMPOSITION | R. J. Reynolds Tobacco Company (US) | 2015-08-19 | — | — | EP | disclosed |
| CN-104780791-A | Tobacco-derived O-methylated flavonoid compositions | REYNOLDS TOBACCO CO R | 2015-07-15 | — | — | CN | disclosed |
| US-20140096780-A1 | TOBACCO-DERIVED COMPOSITION | R.J. REYNOLDS TOBACCO COMPANY (US) | 2014-04-10 | — | — | US | disclosed |
| EP-1781235-B1 | ANTI-ALLERGY ACTIVITIES OF ZINGIBER ZERUMBET (L.) SMITH | WHOLESOME LIFE SCIENCE CO LTD (TW) | 2013-12-25 | — | — | EP | disclosed |
| US-8299119-B2 | Biologically active compounds | Bio-Active Export Pty. Ltd. (AU) | 2012-10-30 | — | — | US | disclosed |
| US-8299119-B2 | Biologically active compounds | Bio-Active Export Pty. Ltd. (AU) | 2012-10-30 | — | — | US | disclosed |
| US-8299119-B2 | Biologically active compounds | Bio-Active Export Pty. Ltd. (AU) | 2012-10-30 | — | — | US | disclosed |
| US-8017147-B2 | Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance | MAZED MOHAMMAD A | 2011-09-13 | — | — | US | disclosed |
| US-20110091353-A1 | Methods for Sterilizing Tissue | BURGESS WILSON | 2011-04-21 | — | — | US | disclosed |
| CN-101982465-A | Flavonoid compound extracted from liquorice and preparation method and application thereof | NINGXIA INST FOR DRUG CONTROL | 2011-03-02 | — | — | CN | disclosed |
| US-7888388-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-7888388-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2011-02-15 | — | — | US | disclosed |
| US-20100021533-A1 | NUTRITIONAL SUPPLEMENT FOR THE PREVENTION OF CARDIOVASCULAR DISEASE, ALZHEIMER'S DISEASE, DIABETES, AND REGULATION AND REDUCTION OF BLOOD SUGAR AND INSULIN RESISTANCE | MAZED MOHAMMAD A | 2010-01-28 | — | — | US | disclosed |
| US-7604823-B2 | Synergistic HIV/AIDS and/or immune disease phyto-nutraceutical composition | Olalde Rangel, Jose Angel (US) | 2009-10-20 | — | — | US | disclosed |
| US-20090252796-A1 | NUTRITIONAL SUPPLEMENT FOR THE PREVENTION OF CARDIOVASCULAR DISEASE, ALZHEIMER'S DISEASE, DIABETES, AND REGULATION AND REDUCTION OF BLOOD SUGAR AND INSULIN RESISTANCE | MAZED MOHAMMAD A | 2009-10-08 | — | — | US | disclosed |
| US-7588788-B2 | administering a ginger extracts from the root of Zingiber zerumbet Sm to treat an allergic rhinitis, asthma and eczema; nutraceuticals as antiinflammatory agents | WHOLESOME LIFE SCIENCE CO., LTD. (TW) | 2009-09-15 | — | — | US | disclosed |
| US-7588788-B2 | administering a ginger extracts from the root of Zingiber zerumbet Sm to treat an allergic rhinitis, asthma and eczema; nutraceuticals as antiinflammatory agents | WHOLESOME LIFE SCIENCE CO., LTD. (TW) | 2009-09-15 | — | — | US | disclosed |
| US-20090221517-A1 | Biologically Active Compounds | BIO-ACTIVES EXPORT PTY., LTD. | 2009-09-03 | — | — | US | disclosed |
| US-20090221517-A1 | Biologically Active Compounds | BIO-ACTIVES EXPORT PTY., LTD. | 2009-09-03 | — | — | US | disclosed |
| US-20090221517-A1 | Biologically Active Compounds | BIO-ACTIVES EXPORT PTY., LTD. | 2009-09-03 | — | — | US | disclosed |
| US-20090214382-A1 | Methods of sterilizing biological mixtures using alpha-keto acids | CLEARANT, INC. | 2009-08-27 | — | — | US | disclosed |
| US-7563467-B2 | Use of an Opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2009-07-21 | — | — | US | disclosed |
| US-7553501-B2 | Immune phyto-neutraceutical composition | Olalde Rangel, Jose Angel (US) | 2009-06-30 | — | — | US | disclosed |
| US-7524975-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7524975-B2 | Peroxisome proliferator activated receptor ligand and process for producing the same | KANEKA CORPORATION (JP) | 2009-04-28 | — | — | US | disclosed |
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | KANEKA CORPORATION (JP) | 2009-02-05 | — | — | US | disclosed |
| EP-1448188-A4 | USE OF AN OPUNTIA FICUS-INDICA EXTRACT AND COMPOUNDS ISOLATED THEREFROM FOR PROTECTING NERVE CELLS | KOREA INST SCI & TECH (KR) | 2008-11-26 | — | — | EP | disclosed |
| EP-1963350-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | BIO-ACTIVES EXPORT PTY. LTD. (AU) | 2008-09-03 | — | — | EP | disclosed |
| WO-2008100977-A2 | CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS | N.V. ORGANON (NL) | 2008-08-21 | — | — | WO | disclosed |
| EP-1781235-A4 | ANTI-HYPERSENSITIVE INFLAMMATION AND ANTI-ALLERGY ACTIVITIES OF ZINGIBER ZERUMBET (L.) SMITH | WHOLESOME LIFE SCIENCE CO LTD (TW) | 2008-07-02 | — | — | EP | disclosed |
| US-20080118582-A1 | Synergistic Inmune Phyto-Nutraceutical Composition | OLALDE RANGEL JOSE ANGEL | 2008-05-22 | — | — | US | disclosed |
| US-20080080998-A1 | Propylene glycol, dimethyl sulfoxide, trehalose and mannitol and gamma radiation; reduce active biological contaminants or pathogens in bone; reduce post-implantation complications, inflammation, immune rejection reactions, calcification | CLEARANT, INC. | 2008-04-03 | — | — | US | disclosed |
| US-20080063658-A1 | SYNERGISTIC HIV/AIDS AND/OR IMMUNE DISEASE PHYTO-NUTRACEUTICAL COMPOSITION | OLALDE RANGEL JOSE ANGEL | 2008-03-13 | — | — | US | disclosed |
| US-20080009451-A1 | Applications of kidney secreted bone growth factor and pharmaceutical use of flavonol and flavonol glycosides for stimulating the secretion of kidney secreted bone growth factor | LONG MIAN | 2008-01-10 | — | — | US | disclosed |
| WO-2007062468-A1 | BIOLOGICALLY ACTIVE COMPOUNDS | BIO-ACTIVES EXPORT PTY. LTD. (AU) | 2007-06-07 | — | — | WO | disclosed |
| EP-1781235-A1 | ANTI-HYPERSENSITIVE INFLAMMATION AND ANTI-ALLERGY ACTIVITIES OF ZINGIBER ZERUMBET (L.) SMITH | Wholesome Life Science Co., Ltd. (TW) | 2007-05-09 | — | — | EP | disclosed |
| US-7211567-B1 | Composition for preventing and treating type I allergy | SUNSTAR, INC. (JP) | 2007-05-01 | — | — | US | disclosed |
| US-20060083799-A1 | Anti-hypersensitive inflammation and anti-allergy activities of Zingiber zerumbet (L.) Smith | WHOLESOME LIFE SCIENCE CO., LTD. | 2006-04-20 | — | — | US | disclosed |
| WO-2006020246-A1 | ANTI-HYPERSENSITIVE INFLAMMATION AND ANTI-ALLERGY ACTIVITIES OF ZINGIBER ZERUMBET (L.) SMITH | LIN TSUNG-CHUNG (US) | 2006-02-23 | — | — | WO | disclosed |
| EP-1618412-A2 | DEVICES AND METHODS FOR DETERMINING THE AMOUNT OF ENERGY ABSORBED DURING IRRADIATION | Clearant, Inc. (US) | 2006-01-25 | — | — | EP | disclosed |
| US-6979829-B2 | Devices and methods for determining the amount of energy absorbed during irradiation | CLEARANT INC. (US) | 2005-12-27 | — | — | US | disclosed |
| US-6908591-B2 | Methods for sterilizing biological materials by irradiation over a temperature gradient | CLEARANT, INC. (US) | 2005-06-21 | — | — | US | disclosed |
| EP-1539254-A2 | METHODS FOR STERILIZING BIOLOGICAL MATERIALS BY IRRADIATION OVER A TEMPERATURE GRADIENT | Clearant, Inc. (US) | 2005-06-15 | — | — | EP | disclosed |
| US-20050106728-A1 | Methods of sterilizing biological mixtures using stabilizer mixtures | CLEARANT INC. | 2005-05-19 | — | — | US | disclosed |
| US-20050069453-A1 | Methods for sterilizing preparations of urokinase | CLEARANT, INC. | 2005-03-31 | — | — | US | disclosed |
| US-20050042311-A1 | Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells | AGRICULTURAL CORPORATIVE SE.JONG CO. (KR) | 2005-02-24 | — | — | US | disclosed |
| WO-2004095062-A2 | DEVICES AND METHODS FOR DETERMINING THE AMOUNT OF ENERGY ABSORBED DURING IRRADIATION | CLEARANT, INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| US-20040211916-A1 | Devices and methods for determining the amount of energy absorbed during irradiation | CLEARANT INC. | 2004-10-28 | — | — | US | disclosed |
| EP-1448188-A1 | USE OF AN OPUNTIA FICUS-INDICA EXTRACT AND COMPOUNDS ISOLATED THEREFROM FOR PROTECTING NERVE CELLS | Korea Institute of Science and Technology (KR) | 2004-08-25 | — | — | EP | disclosed |
| US-20040091388-A1 | Methods for sterilizing biological materials by multiple rates | CLEARANT, INC. | 2004-05-13 | — | — | US | disclosed |
| US-20040086420-A1 | Methods for sterilizing serum or plasma | CLEARANT, INC. | 2004-05-06 | — | — | US | disclosed |
| US-20040033160-A1 | Methods for sterilizing biological materials by irradiation over a temperature gradient | CLEARANT, INC. | 2004-02-19 | — | — | US | disclosed |
| WO-2004009137-A2 | METHODS FOR STERILIZING BIOLOGICAL MATERIALS BY IRRADIATION OVER A TEMPERATURE GRADIENT | CLEARANT, INC. (US) | 2004-01-29 | — | — | WO | disclosed |
| WO-2004009143-A1 | METHODS FOR STERILIZING BIOLOGICAL MATERIALS BY MULTIPLE RATES | CLEARANT, INC. (US) | 2004-01-29 | — | — | WO | disclosed |
| US-6682695-B2 | GAMMA IRRADIATING FETAL BOVINE SERUM AT VARIED DOSAGES | CLEARANT, INC. | 2004-01-27 | — | — | US | disclosed |
| WO-2003092745-A1 | METHODS FOR STERILIZING TISSUES USING CRYOPRESERVATIVES | CLEARANT, INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| US-20030185702-A1 | Methods for sterilizing tissue | CLEARANT, INC. | 2003-10-02 | — | — | US | disclosed |
| US-20030180181-A1 | Methods for sterilizing tissue | CLEARANT, INC. | 2003-09-25 | — | — | US | disclosed |
| US-20030162163-A1 | Method of sterilizing heart valves | CLEARANT, INC. | 2003-08-28 | — | — | US | disclosed |
| US-20030161753-A1 | Methods for sterilizing biological materials by multiple rates | CLEARANT, INC. | 2003-08-28 | — | — | US | disclosed |
| WO-2003065802-A1 | METHODS FOR STERILIZING TISSUE | CLEARANT, INC. (US) | 2003-08-14 | — | — | WO | disclosed |
| WO-2003059146-A2 | METHOD OF STERILIZING HEART VALVES | CLEARANT, INC. (US) | 2003-07-24 | — | — | WO | disclosed |
| US-20030124023-A1 | Method of sterilizing heart valves | CLEARANT, INC. | 2003-07-03 | — | — | US | disclosed |
| WO-2003037324-A1 | USE OF AN OPUNTIA FICUS-INDICA EXTRACT AND COMPOUNDS ISOLATED THEREFROM FOR PROTECTING NERVE CELLS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2003-05-08 | — | — | WO | disclosed |
| WO-2003035238-A2 | METHODS FOR COMBATING BIO-TERRORISM | CLEARANT, INC. (US) | 2003-05-01 | — | — | WO | disclosed |
| WO-2003030949-A1 | METHODS OF STERILIZING BIOLOGICAL MATERIALS | CLEARANT INC. (US) | 2003-04-17 | — | — | WO | disclosed |
| US-20030064000-A1 | Methods of sterilizing biological mixtures using stabilizer mixtures | CLEARANT, INC. | 2003-04-03 | — | — | US | disclosed |
| WO-2003026705-A1 | METHODS FOR STERILIZING BIOLOGICAL MATERIALS USING FLAVONOID/FLAVONOL STABILIZERS | CLEARANT, INC. (US) | 2003-04-03 | — | — | WO | disclosed |
| WO-2003026704-A1 | METHODS OF STERILIZING BIOLOGICAL MIXTURES USING STABILIZER MIXTURES | CLEARANT, INC. (US) | 2003-04-03 | — | — | WO | disclosed |
| US-20030059338-A1 | Methods for sterilizing biological materials using flavonoid/flavonol stabilizers | CLEARANT, INC. | 2003-03-27 | — | — | US | disclosed |
| US-20030012687-A1 | Methods of sterilizing biological materials | CLEARANT, INC. | 2003-01-16 | — | — | US | disclosed |
| EP-0290442-A4 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS. | CHEMEX PHARMACEUTICALS INC (US) | 1990-07-03 | — | — | EP | disclosed |
| WO-1990006104-A1 | USE OF KAEMPFEROL AND CERTAIN DERIVATIVES THEREOF FOR THE PREPARATION OF A COSMETIC OR PHARMACEUTICAL COMPOSITION | LVMH RECHERCHE (FR) | 1990-06-14 | — | — | WO | disclosed |
| EP-0290442-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-11-17 | — | — | EP | disclosed |
| US-4774229-A | ANTITUMOR AGENTS, SKIN DISORDERS, CANCER TREATMENT | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-09-27 | — | — | US | disclosed |
| WO-1988003805-A1 | PHARMACOLOGICALLY ACTIVE COMPOUNDS AND MIXTURES THEREOF, ORGANIC COMPOSITIONS AND METAL SALTS | CHEMEX PHARMACEUTICALS, INC. (US) | 1988-06-02 | — | — | WO | disclosed |
| WO-1987006833-A1 | MODIFICATION OF PLANT EXTRACTS FROM ZYGOPHYLLACEAE | CHEMEX PHARMACEUTICALS, INC. (US) | 1987-11-19 | — | — | WO | disclosed |
| WO-1987006833-A1 | MODIFICATION OF PLANT EXTRACTS FROM ZYGOPHYLLACEAE | CHEMEX PHARMACEUTICALS, INC. (US) | 1987-11-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221517-A1 | Biologically Active Compounds | MPO, CAT, CTSA | POLH 1790/4885CYP3A4 1575/4885CYP2D6 1355/4885 |
| US-20190231739-A1 | NEW USE OF CHROMONE DERIVATIVE AS PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF FIBROSIS USING EMT INHIBITORY ACTIVITY | CDH1, SMAD3, SMAD2 | POLH 4729/4885CYP3A4 1926/4885CYP2D6 3488/4885 |
| US-20200323816-A1 | KAEMPFEROL ANALOG-CONTAINING COMPOSITION | MYOF, VEGFA, KTN1 | POLH 400/4885CYP3A4 629/4885CYP2D6 3524/4885 |
| US-20210228540-A1 | KAEMPFEROL ANALOG-CONTAINING COMPOSITION | MYOF, KTN1, KIF18A | POLH 292/4885CYP3A4 854/4885CYP2D6 3515/4885 |
| US-20090036519-A1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR LIGAND AND PROCESS FOR PRODUCING THE SAME | PPARG, PPARA, PPARD | POLH 3069/4885CYP3A4 1011/4885CYP2D6 1911/4885 |
| US-10744113-B2 | Use of chromone derivative as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity | CDH1, SMAD3, SMAD2 | POLH 4767/4885CYP3A4 1435/4885CYP2D6 3185/4885 |
| US-20260117236-A1 | METHODS AND COMPOSITIONS FOR MODULATING TRICHOME DENSITY AND FLAVOR MOLECULE SECRETION | TAS2R50, TAS2R30, TAS2R31 | POLH 2288/4885CYP3A4 2043/4885CYP2D6 2495/4885 |
| US-20050042311-A1 | Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells | ACHE, CHAT, NOTUM | POLH 3904/4885CYP3A4 3221/4885CYP2D6 3559/4885 |
| US-20170239211-A1 | USE OF CHROMONE DERIVATIVE AS PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF FIBROSIS USING EMT INHIBITORY ACTIVITY | CDH1, SMAD3, SMAD2 | POLH 4767/4885CYP3A4 1435/4885CYP2D6 3185/4885 |
| US-12577526-B2 | Massively parallel on-chip construction of synthetic microbial communities | STUB1, SAMM50, CD14 | POLH 1173/4885CYP3A4 1640/4885CYP2D6 1252/4885 |
| US-10744114-B2 | Use of eupatilin as pharmaceutical composition for prevention and treatment of fibrosis using EMT inhibitory activity | SMAD2, CDH1, SMAD3 | POLH 4834/4885CYP3A4 2771/4885CYP2D6 3750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.